Angiotensin-Converting Enzyme Inhibitor / Angiotensin II Receptor Blocker in COVID-19: a Double-edged Sword or a Myth. (2020). Nepalese Medical Journal, 3(1), 309-312. https://doi.org/10.3126/nmj.v3i1.28726